Post-treatment follow-up of patients is not new. Traditional follow-up studies may last two to five years, while long-term ...

Daiichi Sankyo’s Vanflyta (quizartinib) has been recommended by the National Institute for Health and Care Excellence (NICE) ...

Merck & Co – known as MSD outside the US and Canada – has received approval from the US Food and Drug Administration (FDA) ...

Novartis’ Kisqali (ribociclib) has been approved by the US Food and Drug Administration (FDA) as part of a combination ...

Merck & Co – known as MSD outside the US and Canada – has shared positive overall survival (OS) results from a late-stage ...

GSK’s “ultra-long-acting” biologic depemokimab has demonstrated a significant reduction in severe asthma exacerbations over ...

GSK has shared positive headline results for its mRNA seasonal influenza vaccine and outlined that it will now progress the ...

Roche’s injectable PD-L1 inhibitor Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) has been approved by the US Food ...

It’s taken nine months since the UK’s vote to leave the European Union for Article 50 to be triggered, officially starting the country’s two-year process of negotiating its divorce from the EU. So ...

Vivactis Global Health The Vivactis Group is one of the world’s largest independent healthcare consulting, communications, and marketing networks. Vivactis Global Health draws upon their rich local ...

Cotswold Conference Centre is a place for companies and organisations to meet, train and teambuild. If you are looking for a flexible, dedicated venue to hold your event, you’ve come to the right ...

Spoonful of Sugar Spoonful of Sugar (SoS) is a unique and diverse team of specialists in illness and medicines-related behaviour, hand-picked from academic, healthcare, communications, creative and ...